About Us

The TriStem Group has been set up by Mr.Ghazi Dhoot and Dr. Ilham Saleh Abuljadayel to further research and develop its retrodifferentiation technology which is used to create stem cells from mature adult cells. The retrodifferentiation technology is based on the results of 12 years of research and currently TriStem is the only company that owns, and is in the process of commercialising, this technology. The main advantage of TriStem’s new process over existing methods of harvesting stem cells is that it provides large quantities of stem cells which are by definition DNA matched and, therefore, bypasses the political and ethical issues concerned with therapeutic cloning.

learn about our research
Dr Ilham Saleh Abuljadayel
Chief Scientific Officer
Dr. Ilham Saleh Abuljadayel, is the sole inventor of the TriStem Technology, and co-founder.
Dr Keith Redpath
Chief Development Officer
Dr. Keith Redpath has been in the life sciences industry for over 30 years, having graduated from Heriot Watt University in Marine Biology, then...
Ghazi Dhoot
Chairman & Commercial Director
Prior to founding TriStem, Ghazi set up the Mergers & Acquisitions Division within the Corporate Finance Group, for The National Commercial...
Richard Williams
Chief Executive Officer
For the majority of his professional career Richard was with Arthur Andersen, where he qualified as Fellow of the Institute of Chartered...

Get In Touch

Contact Us